⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL497934 | 0.92 | — | — | |
| SCHEMBL169425 | 0.89 | — | — | |
| SCHEMBL604339 | 0.89 | — | — | |
| SCHEMBL21467045 | 0.89 | CHRM5 (0.39) | — | |
| SCHEMBL322743 | 0.84 | — | — | |
| SCHEMBL14616112 | 0.81 | SIGMAR1 (0.33) | — | |
| SCHEMBL2686980 | 0.78 | CHRM5 (0.33) | — | |
| Hydrochloric Acid SCHEMBL19732802 | 0.77 | — | — | |
| SCHEMBL13817489 | 0.76 | SIGMAR1 (0.34) | — | |
| SCHEMBL13901017 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 405 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113717170-A | Estrogen receptor modulators | 里科瑞尔姆IP控股有限责任公司 | 2021-11-30 | — | — | CN | claimed |
| US-20210330651-A1 | ESTROGEN RECEPTOR MODULATORS | RECURIUM IP HOLDINGS, LLC | 2021-10-28 | — | — | US | claimed |
| CN-112745316-A | Estrogen receptor modulators | 里科瑞尔姆IP控股有限责任公司 | 2021-05-04 | — | — | CN | claimed |
| CN-112679495-A | Estrogen receptor modulators | 里科瑞尔姆IP控股有限责任公司 | 2021-04-20 | — | — | CN | claimed |
| EP-3621619-A1 | COMPOUNDS AND METHODS FOR TREATMENT OF VISCERAL PAIN | Arena Pharmaceuticals, Inc. (US) | 2020-03-18 | — | — | EP | claimed |
| US-20200078358-A1 | Compounds and Methods for Treatment of Visceral Pain | ARENA PHARMACEUTICALS, INC. | 2020-03-12 | — | — | US | claimed |
| CN-110709085-A | Compounds and methods for treating visceral pain | 艾尼纳制药公司 | 2020-01-17 | — | — | CN | claimed |
| EP-3442971-A1 | ESTROGEN RECEPTOR MODULATORS | Zeno Royalties & Milestones, LLC (US) | 2019-02-20 | — | — | EP | claimed |
| US-20180354907-A1 | CANNABINOID RECEPTOR MODULATORS | ARENA PHARMACEUTICALS, INC. | 2018-12-13 | — | — | US | claimed |
| WO-2018208848-A1 | COMPOUNDS AND METHODS FOR TREATMENT OF VISCERAL PAIN | ARENA PHARMACEUTICALS, INC. (US) | 2018-11-15 | — | — | WO | claimed |
| WO-2008006104-A2 | ENHANCED OXYGEN CELL CULTURE PLATFORMS | UNIVERSITY OF MIAMI (US) | 2008-01-10 | — | — | WO | claimed |
| US-20080009027-A1 | Enhanced Oxygen Cell Culture Platforms | UNIVERSITY OF MIAMI (US) | 2008-01-10 | — | — | US | claimed |
| US-7081092-B2 | Methods and apparatus for monitoring and quantifying the movement of fluid | IMCOR PHARMACEUTICAL COMPANY (US) | 2006-07-25 | — | — | US | claimed |
| CN-1213974-C | Process for producing fluoroolefins | DU PONT (US) | 2005-08-10 | — | — | CN | claimed |
| US-20050049484-A1 | Methods and apparatus for monitoring and quantifying the movement of fluid | TARGESON, INC. | 2005-03-03 | — | — | US | claimed |
| US-6802813-B2 | Methods and apparatus for monitoring and quantifying the movement of fluid | IMCOR PHARMACEUTICAL CO. | 2004-10-12 | — | — | US | claimed |
| US-20030220563-A1 | Methods and apparatus for monitoring and quantifying the movement of fluid | TARGESON, INC. | 2003-11-27 | — | — | US | claimed |
| CN-1353681-A | Process for manufacture of fluoroolefins | DU PONT (US) | 2002-06-12 | — | — | CN | claimed |
| US-20020065467-A1 | Methods and apparatus for monitoring and quantifying the movement of fluid | SCHUTT ERNEST G (US) | 2002-05-30 | — | — | US | claimed |
| WO-1998053855-A1 | METHODS AND APPARATUS FOR MONITORING AND QUANTIFYING THE MOVEMENT OF FLUID | ALLIANCE PHARMACEUTICAL CORP. (US) | 1998-12-03 | — | — | WO | claimed |